Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
| Air Freight & Logistics Industry | Industrials Sector | Jerrell W. Shelton CEO | XFRA Exchange | 229050307 CUSIP |
| US Country | 688 Employees | - Last Dividend | 5 Feb 2010 Last Split | 15 Mar 2005 IPO Date |
Cryoport, Inc. is a pivotal player in the temperature-controlled supply chain industry, specializing in solutions for various sectors including biopharma/pharma, animal health, and human reproductive medicine. The company's reach spans across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, making it a global provider. Established in 1999 and headquartered in Brentwood, Tennessee, Cryoport has carved a niche in offering innovative and reliable logistics and storage solutions tailored for the management of temperature-sensitive biological materials.